Filter element with retractable guidewire tip

Information

  • Patent Grant
  • 8328842
  • Patent Number
    8,328,842
  • Date Filed
    Monday, February 7, 2011
    13 years ago
  • Date Issued
    Tuesday, December 11, 2012
    11 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Shumate; Victoria P
    Agents
    • Sughrue Mion, PLLC
    • Feuchtwang; Jonathan
Abstract
A medical guidewire assembly comprises a guidewire having a flexible tip. A medical device such as a collapsible filter for use as an embolic protection device is mounted on the guidewire. The filter is advanced through a body lumen with the guidewire tip extending distally. A variable thickness guidewire (having a recess or thinner segment between thicker segments) can be employed. At a first location the filter is advanced relative to the tip to a location which is distally advanced from the first location. Placement of the filter in an optimal distal location is thereby achieved.
Description
FIELD OF INVENTION

This invention relates to a filter element for a transcatheter embolic protection device.


INTRODUCTION

The invention is particularly concerned with filter elements for transcatheter embolic protection devices of the type described in our WO-A-9923976. One type of such embolic filter essentially comprises a filter body mounted on an associated collapsible support frame which can be collapsed against the guidewire by means of a catheter for deployment of the filter through a patient's vascular system. Upon retraction of the catheter the support frame and filter body expand outwardly from the guidewire across a blood vessel within which the filter is positioned to filter blood flowing through the blood vessel.


One problem with the filter device is that there is a guidewire tip on the distal end which is required for guiding the filter into a desired position. The guidewire tip needs to be relatively long to provide a smooth tip transition. However, the guidewire distal tip may interfere with the optimal placement of the filter element.


The present invention is directed towards overcoming this problem.


STATEMENTS OF INVENTION

According to the invention there is provide a medical guidewire assembly comprising:


a guidewire having a flexible tip at a distal end of the guidewire;


a medical device mounted near the distal end of the guidewire proximally of the tip, the medical device being movable relative to the tip for adjustment of the amount of the tip extending distally of the medical device;


and means to limit the movement of the medical device relative to the tip.


In a preferred embodiment of the invention the means to limit the movement of the medical device comprise one or more stiff limiting elements.


Preferably at least one limiting element is provided on the guidewire. The limiting element may be fixedly mounted to the guidewire. Alternatively, the limiting element is slidably mounted on the guidewire. In this case preferably the assembly includes stop means to limit slidable movement of the limiting element relative to the guidewire. The stop means to limit slidable movement of the limiting element preferably comprises a pair of stops spaced axially apart along the guidewire. The stops may be provided by abutment surfaces formed in the guidewire.


In a preferred embodiment of the invention at least one limiting element is mounted to the medical device. Preferably the limiting element is mounted to the medical device at the proximal end of the medical device. In one arrangement the limiting element is mounted intermediate proximal and distal ends of the medical device.


In one embodiment of the invention at least one limiting element is stiff relative to the guidewire.


Alternatively or additionally at least one limiting element is compliant relative to the guidewire.


Preferably the medical device and the tip are slidable relative to each other. Ideally, the medical device has a receiver slot for reception of at least portion of the tip. In one embodiment of the invention the tip is fully retractable within the receiver slot.


In a particularly preferred embodiment of the invention the medical device is a collapsible embolic filter mounted on a tubular sleeve which is slidably mounted on the guidewire adjacent the distal end of the guidewire, the sleeve having a bore through which the guidewire passes, said bore forming a receiver slot for reception of the flexible tip of the guidewire which is at least partially retractable within the bore of the sleeve.


Preferably the tip is fully retractable within the bore of the sleeve.


In one embodiment a guidewire limiting element is mounted to the guidewire proximal of the embolic filter and a filter limiting element is mounted to the filter within the bore of the sleeve, the guidewire being movable relative to the filter between the first and second limiting elements. In this case preferably the guidewire has an abutment which is engagable with the filter limiting element when the guidewire tip is retracted. In one embodiment the abutment is provided by a shoulder of the tip.


In one arrangement the filter limiting element is provided at a proximal end of the filter.


In another arrangement the filter limiting element is provided intermediate proximal and distal ends of the filter.


In another embodiment of the invention a guidewire limiting element is mounted to the guidewire intermediate proximal and distal ends of the filter and the filter has a proximal filter limiting element and a distal filter limiting element, the guidewire limiting element being movable with the guidewire between the proximal and distal filter limiting elements.


In one case the guidewire tip is retractable proximally of the distal filter limiting element.


Preferably the guidewire limiting element is movable on the guidewire. In this case the assembly includes stop means to limit slidable movement of the guidewire limiting element relative to the guidewire. The stop means may comprise a pair of stops spaced axially apart along the guidewire. The stops may be provided by abutment surfaces formed in the guidewire. In one embodiment the guidewire has a recessed portion of reduced diameter on which the guidewire limiting element is mounted.


In another aspect the invention provides an embolic protection device comprising:


a collapsible filter element mounted on a filter carrier for delivery through a vascular system of a patient;


the filter element being movable between a collapsed stored position against the filter carrier for movement through the vascular system, and an expanded position for occluding a blood vessel such that blood passing through the blood vessel is delivered through the filter element;


the filter element comprising a collapsible filter body having an inlet end and an outlet end;


the inlet end of the filter body having one or more inlet openings sized to allow blood and embolic material enter the filter body; the outlet end of the filter body having a plurality of outlet openings sized to allow through passage of blood but to retain undesired embolic material within the filter body;


the collapsible filter element being slidably mounted on the filter carrier for axial movement of the filter element along the filter carrier; and


means to limit the movement of the filter element relative to the filter carrier, the means being arranged to allow a distal end of the filter carrier to be substantially retracted into the filter element.


In one embodiment of the invention the means to limit the movement of the filter element comprise one or more limiting elements.


At least one limiting element is preferably provided on the filter carrier.


The limiting element may be fixedly mounted on the filter carrier.


Alternatively the limiting element is slidably mounted on the filter carrier. In this case the device preferably includes stop means to limit the movement of the limiting element relative to the filter carrier. The means to limit the movement of the limiting element may comprise a pair of stops spaced axially apart along the filter carrier. The stops may be provided by abutment surfaces formed on the filter carrier.


In a preferred embodiment of the invention at least one limiting element is mounted to the filter element. The limiting element may be mounted to the filter element intermediate the proximal and distal ends of the filter element.


In a further embodiment of the invention the filter element is mounted on a guidewire such that the guidewire has freedom to rotate and/or move axially independently of the filter. More preferably the wire has complete freedom to rotate independently of the filter and has limited axial movement. The limit of axial movement is determined by stops mounted on or connected to the wire. Ideally the wire can move 100 mm in the axial direction independent of the filter. More ideally the wire can move less than 50 mm independently of the filter. This embodiment facilitates the maintenance of filter position during the exchange of catheters and permits the steering of the wire independent of the filter.


In one embodiment of the invention at least one limiting element is stiff relative to the filter carrier. Alternatively or additionally at least one limiting element is compliant relative to the filter carrier.


The limiting element may be mounted to the filter element at the proximal end of the filter element.


In a particularly preferred embodiment of the invention the filter carrier is a guidewire. Preferably the distal end of the guidewire includes a guiding tip which may be substantially retracted into the filter element.


The invention also provides a method for positioning a medical device in a body lumen comprising the steps of:


providing a medical guidewire assembly of the invention;


advancing the assembly into a body lumen with the guidewire tip extending distally of the medical device to a first location;


moving the medical device relative to the tip to advance the medical device to a second location which is distally advanced from the first location.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will be more clearly understood by the following description of some of the embodiments thereof, given by way of example only, with reference to the accompanying drawings, in which:



FIG. 1 is partially sectioned elevational view of an embolic protection device;



FIG. 2 is a schematic sectional elevational view of the embolic protection device of FIG. 1;



FIG. 3 is a detail sectional view of a portion of the device of FIG. 1;



FIG. 4 is a longitudinal cross sectional view of the device of FIG. 1;



FIG. 5 is a cross sectional view of a distal end of the device of FIG. 1;



FIG. 6 is a view on the line A-A in FIG. 4;



FIG. 7 is a perspective view of a filter body of the device of FIGS. 1 to 6;



FIG. 8 is a side elevational view of the filter body of FIG. 7;



FIG. 9 is a view on a proximal end of the filter body;



FIG. 10 is a perspective view of a support frame of the device of FIGS. 1 to 6;



FIG. 11 is a side elevational view of the support frame;



FIG. 12 is a perspective view illustrating the manufacture of the support frame;



FIG. 13 is a view of the support frame and filter body assembly;



FIG. 14 is a side partially cross sectional view of a filter body and guidewire according to one embodiment of the invention in one position of use;



FIG. 15 is a side view similar to FIG. 14 in another position of use;



FIG. 16 is a side, partially cross sectional view of a filter body and guidewire according to another embodiment of the invention in one 5 position of use;



FIG. 17 is a side view similar to FIG. 16 in another position of use;



FIG. 18 is a side partially cross sectional view of a filter body and guidewire according to a further embodiment of the invention in one position of use;



FIGS. 19 and 20 are side views similar to FIG. 18 in other positions of use; and



FIGS. 21 to 23 are side, partially cross sectional views of a filter body and guidewire according to a further embodiment of the invention in different positions of use.





DETAILED DESCRIPTION

Referring to FIGS. 1 to 13 there is illustrated an embolic protection device as described in our WO-A-9923976 indicated generally by the reference number 100. The device 100 has a guidewire 101 with a proximal end 102 and a distal end 103. A tubular sleeve 104 is slidably mounted on the guidewire 101. A collapsible filter 105 is mounted on the sleeve 104, the filter 105 being movable between a collapsed stored position against the sleeve 104 and an expanded position as shown in the drawings extended outwardly of the sleeve 104 for deployment in a blood vessel.


The sleeve 104 is slidable on the guidewire 101 between a pair of spaced-apart end stops, namely an inner stop 106 and an outer stop which in this case is formed by a spring tip 107 at the distal end 103 of the guidewire 101.


The filter 105 comprises a filter body 110 mounted over a collapsible support frame 111. The filter body 110 is mounted to the sleeve 104 at each end, the body 110 being rigidly attached to a proximal end 112 of the sleeve 104 and the body 110 being attached to a collar 115 which is slidable along a distal end 114 of the sleeve 104. Thus the distal end of the body 110 is longitudinally slidable along the sleeve 104. The support frame 111 is also fixed at the proximal end 112 of the sleeve 104. A distal end 116 of the support frame 111 is not attached to the sleeve 104 and is thus also free to move longitudinally along the sleeve 104 to facilitate collapsing the support frame 111 against the sleeve 104. The support frame 111 is such that it is naturally expanded as shown in the drawings and can be collapsed inwardly against the sleeve 104 for loading in a catheter 118 or the like.


The filter body 105 has large proximal inlet openings 117 and small distal outlet openings 119. The proximal inlet openings 117 allow blood and embolic material to enter the filter body, while, the distal outlet openings 119 allow through passage of blood but retain undesired embolic material within the filter body.


An olive guide 120 is mounted at a distal end of the sleeve 104 and has a cylindrical central portion 121 with tapered ends 122, 123. The distal end 122 may be an arrowhead configuration for smooth transition between the catheter and olive surfaces. The support frame 111 is shaped to provide a circumferential groove 125 in the filter body 110. If the filter is too large for a vessel, the body may crease and this groove 125 ensures any crease does not propagate along the filter.


Enlarged openings are provided at a proximal end of the filter body 110 to allow ingress of blood and embolic material into an interior of the body 110.


In use, the filter 105 is mounted in a collapsed state within a distal end of the catheter 118 and delivered to a deployment site. When the filter is correctly positioned the catheter 118 is retracted allowing the support frame 111 to expand expanding the filter body 110 across the vessel in which the filter is mounted. Blood and emboli can enter the enlarged openings at a proximal end of the filter body 110. The blood will pass through the filter body, however, the openings or pores in the filter body are sized so as to retain the embolic material. After use, a retrieval catheter 18 is delivered along the guidewire 101 and slid over the filter 105 engaging the proximal inlet end 112 first to close the openings and then gradually collapsing the filter body against the sleeve 104 as the catheter 118 advances over the filter 105. Once the filter 105 is fully loaded in the catheter 118, it can then be withdrawn.


It will be noted that a proximal end of the filter is fixed and a distal end of the filter is longitudinally movable along the sleeve to facilitate collapsing of the filter body.


Further, the catheter engages the proximal end of the filter body first thus closing the filter body inlet and preventing escape of embolic material from the filter body as the filter body is being collapsed.


The outer filter body 110 is preferably of a resilient biocompatible elastomeric material. The material may be a polyurethane based material. There are a series of commercially available polyurethane materials that may be suitable. These are typically based on polyether or polycarbonate or silicone macroglycols together with diisocyanate and a diol or diamine or alkanolamine or water chain extender. Examples of these are described in EP-A-461,375 and U.S. Pat. No. 5,621,065. In addition, polyurethane elastomers manufactured from polycarbonate polyols as described in U.S. Pat. No. 5,254,622 (Szycher) are also suitable.


The filter material may also be a biostable polycarbonate urethane article an example of which may be prepared by reaction of an isocyanate, a chain extender and a polycarbonate copolymer polyol of alkyl carbonates. This material is described in our WO-A-9924084. The filter material may be manufactured from a block and cut into a desired shape. However the filter is preferably formed by dipping a rod of desired geometry into a solution of the material which coats the rod. The rod is then dissolved. The final geometry of the filter may be determined in the dipping step or the final geometry may be achieved in a finishing operation. Typically the finishing operations involve processes such as mechanical machining operations, laser machining or chemical machining.


The filter body is of hollow construction and is formed as described above by dipping a rod in a solution of polymeric material to coat the rod. The rod is then dissolved, leaving a hollow body polymeric material. The rod may be of an acrylic material which is dissolved by a suitable solvent such as acetone.


The polymeric body thus formed is machined to the shape illustrated in FIGS. 1 to 13. The final machined filter body comprises an inlet or proximal portion 210 with a proximal neck 212, and outlet or distal portion 213 with a distal neck 214, and an intermediate portion 215 between the proximal and distal portions.


The inlet holes 117 are provided in the proximal portion 210 which allow the blood and embolic material to flow into the filter body. In this case the proximal portion 210 is of generally conical shape to maximize the hole size.


The intermediate portion 215 is also hollow and in this case is of generally cylindrical construction. This is important in ensuring more than simple point contact with the surrounding blood vessel. The cylindrical structure allows the filter body to come into soft contact with the blood vessel to avoid damaging the vessel wall.


The intermediate portion 215 is provided with a radial stiffening means, in this case in the form of a radial strengthening ring or rim 220. The ring 220 provides localized stiffening of the filter body without stiffening the material in contact with the vessel. Such an arrangement provides appropriate structural strength so that line apposition of the filter body to the vessel wall is achieved. It is expected that other geometries of stiffening means will achieve a similar result.


The tubular intermediate portion 215 is also important in maintaining the stability of the filter body in situ to retain captured emboli and to ensure that flow around the filter is minimized. For optimum stability we have found that the ratio of the axial length of the intermediate portion 215 of the filter body to the diameter of the intermediate portion 215 is preferably at least 0.5 and ideally greater than 1.0.


The collapsible support frame 111 has four foldable arms 290 which are collapsed for deployment and upon release extend outwardly to expand the filter body 110.


The support frame 111 can be manufactured from a range of metallic or polymeric components such as a shape memory alloy like nitinol or a shape memory polymer or a shaped stainless steel or metal with similar properties that will recover from the deformation sufficiently to initiate opening of the filter body 110.


The support frame may be formed as illustrated in FIG. 12 by machining slots in a tube 291 of shape memory alloy such as nitinol. On machining, the unslotted distal end of the tube forms a distal collar 293 and the unslotted proximal end of the tube forms a proximal collar 294. In use, the distal collar 293 is slidably moveable along the tubular sleeve 104 which in turn is slidably mounted on the guidewire 101 for deployment and retrieval. The proximal collar 294 is fixed relative to the tubular sleeve 104.


To load the filter the sub assembly of the support frame and filter body is pulled back into the catheter 118 to engage the distal stop 107. The support arms 290 are hinged inwardly and the distal collar 293 moves forward along the tubular sleeve 104. As the support arms 290 enter the catheter 118 the filter body 110 stretches as the filter body collar 115 slides along the tubular sleeve 104 proximal to the olive 120. On deployment, the catheter 118 is retracted proximally along the guidewire 101 initially bringing the collapsed filter assembly with it until it engages the proximal stop 106. The catheter sleeve then begins to pull off the filter, freeing the support arms 290 to initiate opening of the filter body to oppose the vessel wall.


For retrieval, a retrieval catheter is introduced by sliding it over the guidewire 101 until it is positioned at the proximal end of the filter body and support frame. Pulling the guidewire 101 will initially engage the distal stop 107 with the filter element and begin to pull it into the retrieval catheter. The initial travel into the delivery catheter acts to close the proximal openings of the filter element, thus entrapping the embolic load. As the filter continues to be pulled back the filter body and the support frame are enveloped in the retrieval catheter. The collapsed filter may then be removed from the patient.


Referring to FIGS. 14 and 15 there is illustrated a medical guidewire assembly according to one embodiment of the invention. A filter 31 is mounted on a guidewire 30 and projecting from the distal end of the guidewire 30 is a guidewire tip 32. The guidewire tip 32 is slidable in a bore 38 in a sleeve 39 of the filter 31. When the filter 31 is being maneuvered into place the guidewire tip 32 facilitates the maneuvering of the filter device. By advancing and retracting the tip 32 relative to the filter assembly 31 it is possible to maneuver the guidewire tip 32 around various portions of the anatomy, for example, where it is particularly tortuous, or where the guidewire tip 32 has to cross lesions. The tip 32 can be partially retracted to give a stiffer tip, or can be fully retracted in the deployment position, FIG. 15.


The guidewire 30 is slidable between a proximal guidewire limiting element 35 on the guidewire 30 and a filter limiting element 37 provided at a proximal end of the filter 31. A stop defined by a shoulder 36 of the tip 32 is engagable against the limiting element 37.


The proximal limiting element 35 and the filter limiting element 37 are of a relatively stiff material, such that upon engagement of the filter 31 with the proximal limiting element 35, or the shoulder 36 with the filter limiting element 37, the limiting elements 35, 37 do not deform. In this way the movement of the filter 31 relative to the guidewire tip 32 is accurately controlled.


One or both of the limiting elements 35, 37 may be of a compliant material. This feature will assist in ensuring that the flexibility of the filter is not affected by the limiting elements.


Referring to FIGS. 16 and 17 there is illustrated a medical guidewire assembly including a filter 42, which is similar to the filter 31 of FIGS. 14 and 15, and the same reference numerals are used to denote similar elements in FIGS. 16 and 17. In this case the guidewire 30 is slidable between a proximal limiting element 35 on the guidewire 30 and a filter limiting element 40 positioned intermediate the proximal and distal ends of the filter 42. A distal stop defined by a shoulder 36 of the tip 32 is engagable against the filter limiting element 40.


Referring to FIGS. 18 to 20 there is illustrated a medical guidewire assembly 30 including a filter 50, which is similar to filters 31 and 42 of FIGS. 14 to 17, and the same reference numerals are used to denote similar elements in FIGS. 18 to 20. In this arrangement a guidewire limiting element 51 is rigidly fixed to the guidewire 30 proximal of the tip 32, the filter 50 being mounted on the guidewire 30 so that the limiting element 51 is intermediate the proximal and distal ends of the filter 50. The guidewire 30 is slidable between a distal limiting element defined by a proximal shoulder 53 (or mobile attachment point) of the filter 50 which is engagable against the guidewire limiting element 51, and a proximal limiting element defined by a distal shoulder 52 (or mobile attachment point) of the filter 50 which is engagable against the guidewire limiting element 51. In this arrangement there is no obstruction to advancement of another medical device over the guidewire 30 to approach the filter 50 from the proximal direction.


Referring to FIGS. 21 to 23 in an alternative embodiment of the invention, the guidewire limiting element 51 is slidably mounted within a recess 53 provided on the guidewire 30 (i.e., a variable thickness guidewire having a thinner segment between thicker segments), the movement of the limiting element 51 relative to the guidewire 30 being limited between a proximal stop provided by a shoulder 55 of the recess and a distal stop provided by a shoulder 54 provided by the guidewire tip 32. This arrangement provides an even greater degree of freedom for movement of the guidewire 30 relative to the filter.


The filter may be placed over or beyond the distal guidewire tip. Thus, the invention facilitates the optimal placement of a filter device in the limited vasculature space available.


Other medical devices may be advanced over the guidewire to approach the filter from the proximal direction without obstruction. Such devices may be for use in performing angioplasty procedures, stenting and the like. Ready access is also provided to perform emergency procedures such as snaring of a medical device or part, and lysis for treatment of a blood clot.


It will be appreciated that while the invention has been described in relation to an embolic protection device it may also be applied to medial guidewire assemblies for placement of other medical devices.


The invention is not limited to the embodiments hereinbefore described which may be varied in both construction and detail.

Claims
  • 1. An embolic protection device for filtering embolic material, debris or clots released during interventional procedures, comprising: a variable thickness guidewire comprising a thinner segment bordered by thicker segments; anda filtering device movable between an expanded configuration and a collapsed configuration, for deploying beyond an area of blockage or clot in a cerebral arterial blood vessel, the filtering device comprising an expansion assembly, a filter membrane, and a mobile attachment point,wherein the filtering device is rotatably mounted on the variable thickness guidewire via the mobile attachment point, such that the filtering device may be rotationally and longitudinally displaced relative to and independently of the guidewire,wherein the filtering device allows ingress of blood and embolic material into the interior of the filter body.
  • 2. The embolic protection device of claim 1, wherein the expansion assembly comprises a plurality of struts comprising a biocompatible material, and the filter membrane has a hemispherical, helical or conical shape.
  • 3. The embolic protection device of claim 1, wherein the guidewire comprises a proximal and a distal stop where the thinner segment of the guidewire meets a thicker segment of the guidewire.
  • 4. The embolic protection device of claim 3, wherein the filtering device comprises a distal mobile attachment point, and a proximal mobile attachment point, and the mobile attachment points are rotatably disposable on the thinner segment of the guidewire between the proximal and distal stops, such that there is rotatory as well as longitudinal mobility of the guidewire through, and independently of, the filtering device between the proximal and distal stops.
  • 5. The embolic protection device of claim 1, wherein the mobile attachment points are short and do not cover the entire length of the thinner segment of the guidewire.
  • 6. The embolic protection device of claim 1, wherein the filter membrane comprises a biopolymer having pores large enough to allow blood cells to pass through the filter but small enough to capture debris and clots that are released during percutaneous neurovascular interventional procedures in the cerebral arterial blood vessels.
  • 7. The embolic protection device of claim 6, wherein the pore openings are sized to capture embolic material of a size greater than 100 microns.
  • 8. The embolic protection device of claim 1, wherein the distal portion of the filtering device is covered by the filter membrane, and wherein the filter membrane comprises a biocompatible elastomeric material.
  • 9. The embolic protection device of claim 1, wherein the distal portion of the filtering device is covered by the filter membrane, and wherein the filter membrane comprises a biostable polycarbonate urethane.
  • 10. The embolic protection device of claim 1, wherein the expansion assembly comprises a plurality of struts.
  • 11. The embolic protection device of claim 10, wherein the plurality of struts are made from a shape memory alloy or shape memory polymer.
  • 12. The embolic protection device of claim 10, wherein the plurality of struts are made from nitinol.
  • 13. The embolic protection device of claim 1, wherein the guidewire comprises a spring tip.
  • 14. The embolic protection device of claim 1, further comprising two mobile attachment points on either end of the filtering device, and the axial length of each mobile attachment point is shorter than the axial length of the thinner segment of the guidewire.
  • 15. The embolic protection device of claim 1, wherein the embolic protection device is not inherently attached to a balloon or a stent while filtering embolic material, debris or clots released during percutaneous neurovascular interventional procedures performed in cerebral arterial blood vessels.
  • 16. A method for collecting embolic material, debris or clots released during percutaneous neurovascular interventional procedures specifically performed in the cerebral arterial blood vessels, comprising: inserting the embolic protection device of claim 1 into a cerebral arterial blood vessel having an area of stenosis or a clot; anddeploying the filtering device distal to the area of blockage or clot and allowing the filtering device to expand to fill the diameter of the cerebral arterial blood vessel.
  • 17. The method of claim 16, further comprising: advancing a catheter towards the area of stenosis or clot;positioning the catheter distal to the area of stenosis or clot; andwithdrawing the catheter,wherein the embolic protection device is advanced to the position distal to the area of stenosis or clot via the catheter.
  • 18. The method of claim 16, wherein a catheter is withdrawn while keeping the guidewire in position distal to the area of stenosis or clot to unsheathe the embolic protection device and allow the device to expand across the vessel; and the expanded shape of the filter membrane is a hemispherical, helical or conical shape.
  • 19. The method of claim 16, further comprising: performing an angioplasty procedure at area of stenosis or clot; andcollecting any debris or clots that are dislodged during the balloon angioplasty in the cerebral arterial blood vessels in the filter membrane of the embolic protection device.
  • 20. The method of claim 16, further comprising; performing a stenting procedure at the area of stenosis or clot; andcollecting any debris or clots that are dislodged during the balloon angioplasty in the cerebral arterial blood vessels in the filter membrane of the embolic protection device.
  • 21. The method of claim 16, further comprising: recovering the embolic protection device by advancing a catheter over the guidewire; andwithdrawing the embolic protection device and the catheter.
Priority Claims (3)
Number Date Country Kind
970789 Nov 1997 IE national
980267 Apr 1998 IE national
PCT/IE99/00039 May 1999 IE national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. application Ser. No. 12/339,375, filed Dec. 19, 2008, now allowed, which is a divisional application of U.S. application Ser. No. 10/189,375, filed Jul. 3, 2002, now U.S. Pat. No. 7,491,216, which is a continuation of U.S. application Ser. No. 09/986,060, filed Nov. 7, 2001, now abandoned, which is a continuation of PCT/IE00/00057, filed May 8, 2000, and which is a continuation-in-part of U.S. application Ser. No. 09/188,472, filed Nov. 9, 1998, now U.S. Pat. No. 6,336,934. In addition, PCT/IE00/00057 claims priority of PCT/IE99/00039, filed May 7, 1999, and U.S. application Ser. No. 09/188,472, now U.S. Pat. No. 6,336,934, claims priority of Irish Patent Application No. 98/0267 filed Apr. 8, 1998, and Irish Patent Application No. 97/0789 filed Nov. 7, 1997. The contents of each of the above-listed applications are incorporated herein by reference in their entirety.

US Referenced Citations (486)
Number Name Date Kind
2854983 Baskin Oct 1958 A
2943626 Dormia Jul 1960 A
3334629 Cohn Sep 1967 A
3435824 Gamponia Apr 1969 A
3540431 Mebin-Uddin Nov 1970 A
3692029 Adair Sep 1972 A
3730185 Cook et al. May 1973 A
3952747 Kimmell, Jr. Apr 1976 A
4295464 Shihata Oct 1981 A
4404971 LeVeen et al. Sep 1983 A
4423725 Baran et al. Jan 1984 A
4425908 Simon Jan 1984 A
4425909 Rieser Jan 1984 A
4445892 Hussein et al. May 1984 A
4493711 Chin et al. Jan 1985 A
4512762 Spears Apr 1985 A
4585000 Hershenson Apr 1986 A
4586919 Taheri May 1986 A
4610662 Weikl et al. Sep 1986 A
4611594 Grayhack et al. Sep 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4650466 Luther Mar 1987 A
4712551 Rayhanabad Dec 1987 A
4723549 Wholey et al. Feb 1988 A
4781177 Lebigot Nov 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4794928 Kletschka Jan 1989 A
4807626 McGirr Feb 1989 A
4817600 Herms et al. Apr 1989 A
4832055 Palestrant May 1989 A
4867156 Stack et al. Sep 1989 A
4873978 Ginsburg Oct 1989 A
4926858 Gifford, III et al. May 1990 A
4927426 Dretler May 1990 A
4957501 Lahille et al. Sep 1990 A
4969891 Gevertz Nov 1990 A
4990156 Lefebvre Feb 1991 A
5011488 Ginsburg Apr 1991 A
5026377 Burton et al. Jun 1991 A
5053008 Bajaj Oct 1991 A
5092839 Kipperman Mar 1992 A
5100423 Fearnot Mar 1992 A
5108419 Reger et al. Apr 1992 A
5122125 Deuss Jun 1992 A
5133733 Rasmussen et al. Jul 1992 A
5171233 Amplatz et al. Dec 1992 A
5178158 De Toledo Jan 1993 A
5192284 Pleatman Mar 1993 A
5192295 Danforth et al. Mar 1993 A
5254622 Nanasawa et al. Oct 1993 A
5256144 Kraus et al. Oct 1993 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5336234 Vigil et al. Aug 1994 A
5354310 Garnic et al. Oct 1994 A
5370657 Irie Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5383887 Nadal Jan 1995 A
5387219 Rappe Feb 1995 A
5405329 Durand Apr 1995 A
5421832 Lefebvre Jun 1995 A
5454788 Walker et al. Oct 1995 A
5540707 Ressemenn et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5593394 Kanesaka et al. Jan 1997 A
5621065 Pudleiner et al. Apr 1997 A
5658296 Bates et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5683451 Lenker et al. Nov 1997 A
5695519 Summers et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5720764 Naderlinger Feb 1998 A
5725519 Penner et al. Mar 1998 A
5766203 Imran et al. Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5769871 Mers Kelly et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5795322 Boudewijn Aug 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5823992 Salmon et al. Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5834449 Thompson et al. Nov 1998 A
5836969 Kim et al. Nov 1998 A
5843167 Dwyer et al. Dec 1998 A
5846260 Maahs Dec 1998 A
5848964 Samuels Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5879697 Ding et al. Mar 1999 A
5882329 Pattrson et al. Mar 1999 A
5895398 Wensel et al. Apr 1999 A
5895410 Forber et al. Apr 1999 A
5897567 Ressemann et al. Apr 1999 A
5902334 Dwyer et al. May 1999 A
5910154 Tsugita et al. Jun 1999 A
5911725 Boury Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5928261 Ruiz Jul 1999 A
5935139 Bates Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5941896 Kerr Aug 1999 A
5947995 Samuels Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5968071 Chevillon Oct 1999 A
5976172 Homsma et al. Nov 1999 A
5984947 Smith Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013093 Nott et al. Jan 2000 A
6027509 Schatz et al. Feb 2000 A
6027520 Tsugita et al. Feb 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6053832 Saito Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059814 Ladd May 2000 A
6066149 Samson et al. May 2000 A
6068645 Tu May 2000 A
6074357 Kaganov et al. Jun 2000 A
6083239 Addis Jul 2000 A
6086577 Ken et al. Jul 2000 A
6086605 Barbut et al. Jul 2000 A
6090097 Barbut et al. Jul 2000 A
6093173 Balceta et al. Jul 2000 A
6096027 Layne Aug 2000 A
6096053 Bates Aug 2000 A
6099534 Bates et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6123715 Amplatz Sep 2000 A
6129739 Khosravi Oct 2000 A
6132458 Staehle et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6146370 Barbut Nov 2000 A
6146404 Kim et al. Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165199 Barbut Dec 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6168604 Cano Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6176849 Yang et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206868 Parodi Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
6238412 Dubrul et al. May 2001 B1
6241703 Levin et al. Jun 2001 B1
6241746 Bosma et al. Jun 2001 B1
6245012 Kleshinski Jun 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254563 Macoviak et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6264663 Cano Jul 2001 B1
6264672 Fisher Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6267777 Bosma et al. Jul 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6273901 Whitcher et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6290710 Cryer et al. Sep 2001 B1
6295989 Connors, III Oct 2001 B1
6306163 Fitz Oct 2001 B1
6319242 Patterson et al. Nov 2001 B1
6325815 Kusleika et al. Dec 2001 B1
6336934 Gilson et al. Jan 2002 B1
6340364 Kanesaka Jan 2002 B2
6346116 Brooks et al. Feb 2002 B1
6348056 Bates et al. Feb 2002 B1
6355051 Sisskind et al. Mar 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6361546 Khosravi Mar 2002 B1
6364895 Greenhalgh Apr 2002 B1
6371935 Macoviak et al. Apr 2002 B1
6371969 Tsugita et al. Apr 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6383206 Gillick et al. May 2002 B1
6391044 Yadav et al. May 2002 B1
6394978 Boyle et al. May 2002 B1
6395014 Macoviak et al. May 2002 B1
6395017 Dwyer et al. May 2002 B1
6398756 Peterson et al. Jun 2002 B2
6402771 Palmer et al. Jun 2002 B1
6406471 Jang et al. Jun 2002 B1
6423032 Parodi Jul 2002 B2
6425909 Dieck et al. Jul 2002 B1
6428489 Jacobsen et al. Aug 2002 B1
6428559 Johnson Aug 2002 B1
6432122 Gilson et al. Aug 2002 B1
6436121 Blom Aug 2002 B1
6443926 Kletschka Sep 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443979 Stalker et al. Sep 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6458139 Palmer et al. Oct 2002 B1
6461370 Gray et al. Oct 2002 B1
6468291 Bates et al. Oct 2002 B2
6482222 Bruckheimer et al. Nov 2002 B1
6485497 Wensel et al. Nov 2002 B2
6485500 Kokish et al. Nov 2002 B1
6485501 Green Nov 2002 B1
6485502 Don Michael et al. Nov 2002 B2
6494895 Addis Dec 2002 B2
6506203 Boyle et al. Jan 2003 B1
6506205 Goldberg et al. Jan 2003 B2
6511492 Rosenbluth Jan 2003 B1
6511496 Huter et al. Jan 2003 B1
6511497 Braun et al. Jan 2003 B1
6511503 Burkett et al. Jan 2003 B1
6514273 Voss et al. Feb 2003 B1
6517550 Konya et al. Feb 2003 B1
6517559 O'Connell Feb 2003 B1
6520978 Blackledge et al. Feb 2003 B1
6527746 Oslund et al. Mar 2003 B1
6530939 Hopkins et al. Mar 2003 B1
6530940 Fisher Mar 2003 B2
6533800 Barbut Mar 2003 B1
6537294 Boyle et al. Mar 2003 B1
6537295 Petersen Mar 2003 B2
6537296 Levinson et al. Mar 2003 B2
6537297 Tsugita et al. Mar 2003 B2
6540722 Boyle et al. Apr 2003 B1
6540767 Walak et al. Apr 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544276 Azizi Apr 2003 B1
6544279 Hopkins et al. Apr 2003 B1
6544280 Daniel et al. Apr 2003 B1
6547760 Samson et al. Apr 2003 B1
6551341 Boylan et al. Apr 2003 B2
6551342 Shen et al. Apr 2003 B1
6558405 McInnes May 2003 B1
6562058 Seguin May 2003 B2
6565591 Brady et al. May 2003 B2
6569184 Huter May 2003 B2
6575995 Huter et al. Jun 2003 B1
6575996 Denison et al. Jun 2003 B1
6575997 Palmer et al. Jun 2003 B1
6582447 Patel et al. Jun 2003 B1
6582448 Boyle et al. Jun 2003 B1
6585756 Strecker Jul 2003 B1
6589263 Hopkins et al. Jul 2003 B1
6589265 Palmer et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6592606 Huter et al. Jul 2003 B2
6592616 Stack et al. Jul 2003 B1
6596011 Johnson et al. Jul 2003 B2
6599307 Huter et al. Jul 2003 B1
6602269 Wallace et al. Aug 2003 B2
6602271 Adams et al. Aug 2003 B2
6602272 Boylan et al. Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6605111 Bose et al. Aug 2003 B2
6610077 Hancock et al. Aug 2003 B1
6616679 Khosravi et al. Sep 2003 B1
6616680 Thielen Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6616682 Joergensen et al. Sep 2003 B2
6620148 Tsugita et al. Sep 2003 B1
6620182 Khosravi Sep 2003 B1
6623450 Dutta Sep 2003 B1
6632236 Hogendijk Oct 2003 B2
6632241 Hancock et al. Oct 2003 B1
6635070 Leeflang et al. Oct 2003 B2
6638294 Palmer Oct 2003 B1
6645220 Huter et al. Nov 2003 B1
6645223 Boyle et al. Nov 2003 B2
6645224 Gilson et al. Nov 2003 B2
6652480 Imran et al. Nov 2003 B1
6652505 Tsugita et al. Nov 2003 B1
6652554 Wholey et al. Nov 2003 B1
6652557 MacDonald Nov 2003 B1
6656202 Papp et al. Dec 2003 B2
6660021 Palmer et al. Dec 2003 B1
6663650 Sepetka et al. Dec 2003 B2
6663651 Krolike et al. Dec 2003 B2
6663652 Daniel et al. Dec 2003 B2
6666882 Bose et al. Dec 2003 B1
6669721 Bose et al. Dec 2003 B1
6682812 Scheckenbach et al. Jan 2004 B2
6695813 Boyle et al. Feb 2004 B1
6726701 Gilson et al. Apr 2004 B2
6726703 Broome et al. Apr 2004 B2
6752819 Brady et al. Jun 2004 B1
6773448 Kusleika et al. Aug 2004 B2
6840950 Stanford et al. Jan 2005 B2
6872216 Daniel et al. Mar 2005 B2
6887256 Gilson et al. May 2005 B2
6963760 Piwowarski Nov 2005 B2
6964670 Shah et al. Nov 2005 B1
7131986 Sirhan et al. Nov 2006 B2
7172614 Boyle et al. Feb 2007 B2
7491215 Vale et al. Feb 2009 B2
20010000799 Wessman et al. May 2001 A1
20010001315 Bates et al. May 2001 A1
20010007947 Kanesaka Jul 2001 A1
20010012951 Bates et al. Aug 2001 A1
20010020175 Yassour et al. Sep 2001 A1
20010025187 Okada Sep 2001 A1
20010031982 Peterson et al. Oct 2001 A1
20010039431 De Vries et al. Nov 2001 A1
20010041908 Levinson et al. Nov 2001 A1
20010044632 Daniel et al. Nov 2001 A1
20020002384 Gilson et al. Jan 2002 A1
20020004667 Adams et al. Jan 2002 A1
20020022858 Demond et al. Feb 2002 A1
20020022860 Borillo et al. Feb 2002 A1
20020026211 Khosravi et al. Feb 2002 A1
20020026213 Gilson et al. Feb 2002 A1
20020032460 Kusleika et al. Mar 2002 A1
20020045916 Gray et al. Apr 2002 A1
20020045918 Suon et al. Apr 2002 A1
20020049467 Gilson et al. Apr 2002 A1
20020049468 Streeter et al. Apr 2002 A1
20020052626 Gilson et al. May 2002 A1
20020052638 Zadno-Azizi May 2002 A1
20020055747 Cano et al. May 2002 A1
20020055767 Forde et al. May 2002 A1
20020058911 Gilson et al. May 2002 A1
20020058963 Vale et al. May 2002 A1
20020062133 Gilson et al. May 2002 A1
20020062135 Mazzocchi et al. May 2002 A1
20020065507 Zadno-Azizi May 2002 A1
20020068954 Foster Jun 2002 A1
20020068955 Khosravi Jun 2002 A1
20020072730 McGill et al. Jun 2002 A1
20020072765 Mazzocchi et al. Jun 2002 A1
20020082525 Oslund et al. Jun 2002 A1
20020082639 Broome et al. Jun 2002 A1
20020091408 Sutton et al. Jul 2002 A1
20020091409 Sutton et al. Jul 2002 A1
20020095141 Belef et al. Jul 2002 A1
20020095170 Krolik et al. Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020095172 Mazzocchi et al. Jul 2002 A1
20020095173 Mazzocchi et al. Jul 2002 A1
20020095174 Tsugita et al. Jul 2002 A1
20020099407 Becker et al. Jul 2002 A1
20020103501 Diaz et al. Aug 2002 A1
20020107541 Vale et al. Aug 2002 A1
20020111648 Kusleika et al. Aug 2002 A1
20020111649 Russo et al. Aug 2002 A1
20020115942 Stanford et al. Aug 2002 A1
20020120286 DoBrava et al. Aug 2002 A1
20020120287 Huter Aug 2002 A1
20020121472 Garner et al. Sep 2002 A1
20020123720 Kuleika et al. Sep 2002 A1
20020123755 Lowe et al. Sep 2002 A1
20020128679 Turovskiy et al. Sep 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020128681 Broome et al. Sep 2002 A1
20020133092 Oslund et al. Sep 2002 A1
20020138094 Borillo et al. Sep 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020143360 Douk et al. Oct 2002 A1
20020143361 Douk et al. Oct 2002 A1
20020151927 Douk et al. Oct 2002 A1
20020156456 Fisher Oct 2002 A1
20020156457 Fisher Oct 2002 A1
20020161390 Mouw Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161393 Demond et al. Oct 2002 A1
20020161395 Douk et al. Oct 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020169414 Kletschka Nov 2002 A1
20020169458 Connors, III Nov 2002 A1
20020169472 Douk et al. Nov 2002 A1
20020169474 Kusleika et al. Nov 2002 A1
20020173815 Hogendijk et al. Nov 2002 A1
20020173817 Kleschka et al. Nov 2002 A1
20020183873 Shadduck Dec 2002 A1
20020188313 Johnson et al. Dec 2002 A1
20020188314 Anderson et al. Dec 2002 A1
20020193825 McGuckin et al. Dec 2002 A1
20020193826 McGuckin et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20020193828 Griffin et al. Dec 2002 A1
20030004536 Boylan et al. Jan 2003 A1
20030004537 Boyle et al. Jan 2003 A1
20030004539 Linder et al. Jan 2003 A1
20030004540 Linder et al. Jan 2003 A1
20030004541 Linder et al. Jan 2003 A1
20030009188 Linder et al. Jan 2003 A1
20030009189 Gilson et al. Jan 2003 A1
20030015206 Roth et al. Jan 2003 A1
20030018354 Roth et al. Jan 2003 A1
20030023265 Forber Jan 2003 A1
20030028238 Burkett et al. Feb 2003 A1
20030032941 Boyle et al. Feb 2003 A1
20030032977 Brady et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030042186 Boyle et al. Mar 2003 A1
20030045898 Harrison et al. Mar 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030060782 Bose et al. Mar 2003 A1
20030060843 Boucher Mar 2003 A1
20030060844 Borillo et al. Mar 2003 A1
20030065354 Boyle et al. Apr 2003 A1
20030069596 Eskuri Apr 2003 A1
20030069597 Petersen Apr 2003 A1
20030078519 Salahieh et al. Apr 2003 A1
20030078614 Salahieh et al. Apr 2003 A1
20030083692 Vrba et al. May 2003 A1
20030083693 Daniel et al. May 2003 A1
20030093106 Brady et al. May 2003 A1
20030100917 Boyle et al. May 2003 A1
20030100918 Duane May 2003 A1
20030105484 Boyle et al. Jun 2003 A1
20030109824 Anderson et al. Jun 2003 A1
20030114879 Euteneuer et al. Jun 2003 A1
20030114880 Hansen et al. Jun 2003 A1
20030120303 Boyle et al. Jun 2003 A1
20030125764 Brady et al. Jul 2003 A1
20030130680 Russell Jul 2003 A1
20030130681 Ungs Jul 2003 A1
20030130682 Broome et al. Jul 2003 A1
20030130684 Brady et al. Jul 2003 A1
20030130685 Daniel et al. Jul 2003 A1
20030130686 Daniel et al. Jul 2003 A1
20030130687 Daniel et al. Jul 2003 A1
20030130688 Daniel et al. Jul 2003 A1
20030135162 Deyette, Jr. et al. Jul 2003 A1
20030135232 Douk et al. Jul 2003 A1
20030139764 Levinson et al. Jul 2003 A1
20030144670 Pavcnik et al. Jul 2003 A1
20030144685 Boyle et al. Jul 2003 A1
20030144686 Martinez et al. Jul 2003 A1
20030144687 Brady et al. Jul 2003 A1
20030144688 Brady et al. Jul 2003 A1
20030144689 Brady et al. Jul 2003 A1
20030150821 Bates et al. Aug 2003 A1
20030153942 Wang et al. Aug 2003 A1
20030153943 Michael et al. Aug 2003 A1
20030158574 Esch et al. Aug 2003 A1
20030163064 Vrba et al. Aug 2003 A1
20030171770 Kusleika et al. Sep 2003 A1
20030171771 Anderson et al. Sep 2003 A1
20030171803 Shimon Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030176885 Broome et al. Sep 2003 A1
20030176886 Wholey et al. Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030181943 Daniel et al. Sep 2003 A1
20030187474 Keegan et al. Oct 2003 A1
20030187475 Tsugita et al. Oct 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030191493 Epstein et al. Oct 2003 A1
20030195555 Khairkhahan et al. Oct 2003 A1
20030199819 Beck Oct 2003 A1
20030204168 Bosma et al. Oct 2003 A1
20030208224 Broome Nov 2003 A1
20030208225 Goll et al. Nov 2003 A1
20030208226 Bruckheimer et al. Nov 2003 A1
20030208227 Thomas Nov 2003 A1
20030208228 Gilson et al. Nov 2003 A1
20030212361 Boyle et al. Nov 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212431 Brady et al. Nov 2003 A1
20030212434 Thielen Nov 2003 A1
20030216774 Larson Nov 2003 A1
20030220665 Eskuri et al. Nov 2003 A1
20030225418 Esksuri et al. Dec 2003 A1
20030229295 Houde et al. Dec 2003 A1
20030229374 Brady et al. Dec 2003 A1
20030233117 Adams et al. Dec 2003 A1
20040010282 Kusleika Jan 2004 A1
20040204737 Boismler et al. Oct 2004 A1
20060030878 Anderson et al. Feb 2006 A1
20060161198 Sakai et al. Jul 2006 A1
20070027522 Chang et al. Feb 2007 A1
20070135833 Talpade et al. Jun 2007 A1
Foreign Referenced Citations (112)
Number Date Country
3706077 Jun 1988 DE
0256683 Feb 1988 EP
0461375 Apr 1991 EP
0533511 Mar 1993 EP
0596172 Nov 1994 EP
0655228 May 1995 EP
0743046 Nov 1996 EP
0759287 Feb 1997 EP
0791340 Aug 1997 EP
0827756 Mar 1998 EP
1123688 Aug 2001 EP
1127556 Aug 2001 EP
1149566 Oct 2001 EP
1172073 Jan 2002 EP
1181900 Feb 2002 EP
1676545 Jul 2006 EP
2580504 Oct 1986 FR
2616666 Dec 1988 FR
2768326 Mar 1999 FR
2020557 Nov 1979 GB
2200848 Aug 1988 GB
8809683 Dec 1988 WO
8907422 Aug 1989 WO
9424946 Nov 1994 WO
9534254 Dec 1995 WO
9534339 Dec 1995 WO
9601591 Jan 1996 WO
9639998 Dec 1996 WO
9703810 Feb 1997 WO
9717021 May 1997 WO
9717100 May 1997 WO
9717914 May 1997 WO
9727808 Aug 1997 WO
9742879 Nov 1997 WO
9824377 Jun 1998 WO
9830265 Jul 1998 WO
9833443 Aug 1998 WO
9838920 Sep 1998 WO
9839053 Sep 1998 WO
9846297 Oct 1998 WO
9849952 Nov 1998 WO
9850103 Nov 1998 WO
9851237 Nov 1998 WO
9916382 Apr 1999 WO
9920335 Apr 1999 WO
9922673 May 1999 WO
9923976 May 1999 WO
9925252 May 1999 WO
9944510 Sep 1999 WO
9944542 Sep 1999 WO
9951167 Oct 1999 WO
9955236 Nov 1999 WO
0007521 Feb 2000 WO
0007656 Feb 2000 WO
0016705 Mar 2000 WO
0021604 Apr 2000 WO
0044428 Aug 2000 WO
0049970 Aug 2000 WO
0056390 Sep 2000 WO
0066031 Nov 2000 WO
0067664 Nov 2000 WO
0067665 Nov 2000 WO
0067666 Nov 2000 WO
0067667 Nov 2000 WO
0067668 Nov 2000 WO
0067669 Nov 2000 WO
0067670 Nov 2000 WO
0067671 Nov 2000 WO
0067829 Nov 2000 WO
0076390 Dec 2000 WO
0100084 Jan 2001 WO
0100087 Jan 2001 WO
0115329 Jan 2001 WO
0108595 Feb 2001 WO
0108596 Feb 2001 WO
0108742 Feb 2001 WO
0108743 Feb 2001 WO
0110343 Feb 2001 WO
0112081 Feb 2001 WO
0115629 Mar 2001 WO
0115630 Mar 2001 WO
0121077 Mar 2001 WO
0121100 Mar 2001 WO
0135857 May 2001 WO
0135858 May 2001 WO
0143662 Jun 2001 WO
0145590 Jun 2001 WO
0145591 Jun 2001 WO
0145592 Jun 2001 WO
0149208 Jul 2001 WO
0149209 Jul 2001 WO
0149215 Jul 2001 WO
0150982 Jul 2001 WO
0152768 Jul 2001 WO
0172205 Oct 2001 WO
0180776 Nov 2001 WO
0180777 Nov 2001 WO
0182830 Nov 2001 WO
0182831 Nov 2001 WO
0187183 Nov 2001 WO
0189413 Nov 2001 WO
0197714 Dec 2001 WO
0243595 Jun 2002 WO
02083225 Oct 2002 WO
03022325 Mar 2003 WO
03047648 Jun 2003 WO
03084434 Oct 2003 WO
03084435 Oct 2003 WO
03084436 Oct 2003 WO
03088805 Oct 2003 WO
03088869 Oct 2003 WO
2004093738 Nov 2004 WO
Related Publications (1)
Number Date Country
20110125182 A1 May 2011 US
Divisions (1)
Number Date Country
Parent 10189375 Jul 2002 US
Child 12339375 US
Continuations (3)
Number Date Country
Parent 12339375 Dec 2008 US
Child 13022040 US
Parent 09986060 Nov 2001 US
Child 10189375 US
Parent PCT/IE00/00057 May 2000 US
Child 09986060 US
Continuation in Parts (1)
Number Date Country
Parent 09188472 Nov 1998 US
Child PCT/IE00/00057 US